AI assistant
IRADIMED CORP — Director's Dealing 2021
Nov 5, 2021
32324_dirs_2021-11-05_336e3944-f6c6-4abc-8c5a-31f0964f84f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-11-02
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-02 | Common Stock | A | 4766 | $1.48 | Acquired | 22034 | Direct |
| 2021-11-02 | Common Stock | S | 4766 | $38.0123 | Disposed | 17268 | Direct |
| 2021-11-03 | Common Stock | A | 16735 | $1.48 | Acquired | 34003 | Direct |
| 2021-11-03 | Common Stock | S | 16735 | $38.0064 | Disposed | 17268 | Direct |
| 2021-11-04 | Common Stock | A | 12285 | $1.48 | Acquired | 29553 | Direct |
| 2021-11-04 | Common Stock | S | 12285 | $38.4536 | Disposed | 17268 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-02 | Stock Options (Right to Buy) | $1.48 | M | 4766 | Disposed | 2023-12-31 | Common Stock (4766) | Direct |
| 2021-11-03 | Stock Options (Right to Buy) | $1.48 | M | 16735 | Disposed | 2023-12-31 | Common Stock (16735) | Direct |
| 2021-11-04 | Stock Options (Right to Buy) | $1.48 | M | 12285 | Disposed | 2023-12-31 | Common Stock (12285) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2: This transaction was executed in multiple trades at prices ranging from $38.00 to 38.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $38.00 to 38.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $38.20 to $39.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.